Zevra Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.968; its P/E ratio is ―; Zevra Therapeutics is scheduled to report earnings on February 28, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Sep 23	Jun 23
Income Statement	-
Total Revenue	$ 3.69M	$ 4.45M	$ 3.42M	$ 2.90M	$ 8.47M
Gross Profit	$ 1.39M	$ 876.00K	$ 3.25M	$ 2.75M	$ 7.79M
EBIT	$ -33.23M	$ -19.86M	$ -15.96M	$ -13.50M	$ -2.65M
EBITDA	$ -31.61M	$ -18.29M	$ -14.39M	$ -13.44M	$ -2.57M
Net Income Common Stockholders	$ -33.23M	$ -19.93M	$ -17.52M	$ -14.04M	$ -2.57M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 89.38M	$ 49.26M	$ 52.72M	$ 83.43M	$ 87.37M
Total Assets	$ 191.55M	$ 144.41M	$ 151.28M	$ 138.98M	$ 105.52M
Total Debt	$ 59.93M	$ 59.47M	$ 44.29M	$ 44.82M	$ 13.79M
Net Debt	$ -29.45M	$ 10.21M	$ -8.43M	$ -38.60M	$ -73.58M
Total Liabilities	$ 121.78M	$ 111.93M	$ 102.47M	$ 71.51M	$ 37.02M
Stockholders Equity	$ 69.77M	$ 32.48M	$ 48.82M	$ 67.47M	$ 68.50M
Cash Flow	-
Free Cash Flow	$ -18.14M	$ -19.11M	$ -16.16M	$ -4.80M	$ -8.73M
Operating Cash Flow	$ -18.14M	$ -19.11M	$ -16.16M	$ -4.63M	$ -8.70M
Investing Cash Flow	$ -31.35M	$ -129.00K	$ 14.79M	$ -44.46M	$ 34.04M
Financing Cash Flow	$ 64.77M	$ 15.33M	$ 1.22M	$ 26.26M	$ 951.00K

Currency in USD

Zevra Therapeutics Earnings and Revenue History

Income Statement >

Zevra Therapeutics Debt to Assets

Balance Sheet >

Zevra Therapeutics Cash Flow

Cash Flow >

Zevra Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing